All Posts

  • An Exciting Scientific Discovery – the RECQL Breast Cancer Susceptibility Gene

    One of the most important elements of the Susan G. Komen mission is funding breast cancer research, and today, we’re excited to share an important breakthrough made possible in part by more than $1 million in Komen funding.

    A study published today in Nature Genetics, marks the discovery of a new breast cancer susceptibility gene called RECQL. Led by Dr. Mohammad Akbari (University of Toronto) and Cezary Cybulski (Pomeranian University, Szczecin, Poland), this work featured an important contribution from Komen Scholar Dr. William Foulkes of McGill University (Montreal, Quebec) who has received long-term support from Komen, and a $1.125 million grant in 2010 for this work.  Working with Quebec colleagues based at McGill and at the University of Laval, Foulkes was able to provided convincing data to support the candidacy of RECQL as a new breast cancer susceptibility gene.

    The research is groundbreaking, because breast cancer susceptibility genes and their associated mutations are difficult to identify. In fact, all of the mutations in breast cancer susceptibility genes that we currently know of (including BRCA1 and BRCA2) account for just half of all inherited breast cancer cases.

    But Dr. Foulkes’ work lays the foundation for more discoveries that may one day help women assess their risk and take action for their health. We learned this from Dr. Mary-Claire King’s identification of the location of the BRCA1 gene in 1990.  Researchers knew then that BRCA1 would be an important gene, but it took several years before it could be determined with certainty that BRCA1 mutation carriers have a 55 to 65 percent chance of developing breast cancer by age 70 (much higher than women at average risk). Or, that women who have a BRCA1 gene mutation are at a higher risk of developing triple negative breast cancer – an aggressive and potentially lethal form of the disease.

    Subsequently, in work also funded by Komen, another important breast cancer gene, PALB2, was found to lead to a 35 percent risk for breast cancer by age 70, showing that these initial discoveries do lead to the acquisition of clinically meaningful data.

    This knowledge led to tests for BRCA and PALB2 gene mutations that have helped women and men with the mutation make decisions about their own health, based on their individual risk. The same potential exists for the RECQL mutation if and when testing for the mutation is available.

    While we know there is still a lot to learn about both the RECQL gene mutations and breast cancer in general, we’re eager and excited to see what the future holds.

    And we are even more inspired to keep funding research that will end this disease.  We fund along the entire cancer spectrum – from causes to cures – to reduce mortality and incidence of breast cancer.

    Read more about the RECQL discovery in our press release.

    Read more about Komen-funded research.

  • Calling on Capitol Hill to Increase Access and Remove Barriers to Breast Cancer Care

    By Kim Beer, Director, Public Policy for Susan G. Komen

    Left to right: Dr. Nancy Cappello, Susan G. Komen President and CEO Dr. Judy Salerno, Rep. Rosa DeLauro & Komen Connecticut CEO Anne Morris.

    Earlier today, 65 Komen Affiliate leaders – many of them breast cancer survivors – from across the country met with their Senators and House Members to push for federal funding for cancer research and early detection through screening.

    Breast cancer doesn’t care about the color of your skin or where you live. It doesn’t care if you’re young or old.

    And it doesn’t care if you are from a blue state or red state.

    More than 230,000 cases of breast cancer will be diagnosed in the U.S. this year. Each of those women and men, along with their families and friends, and the more than three million breast cancer survivors in the U.S. today, have concerns about access to care, getting the best treatment, and what the future holds.

    For more than 30 years, Komen has worked to make sure their voices are heard, calling on lawmakers to make sure that all women have access to breast cancer services.

    This week, we went to work again at the 2015 Komen Advocacy Summit. Representatives from our nationwide Network of Affiliates were joined by former Good Morning America host Joan Lunden and the talented Nikia Hammonds-Blakely who shared their own experiences facing breast cancer.

    Local Komen leaders had the opportunity to meet with more than 350 Congressional offices to discuss how to better serve women in their communities and some of Komen’s key priorities this year:

    Left to right: Susan G. Komen Founder Nancy G. Brinker, Breast Cancer Survivor Joan Lunden and Susan G. Komen President and CEO Dr. Judy Salerno.

    -          Ensuring Access to Breast Health Services through support of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) which provides breast cancer services to low-income, uninsured and underinsured women who do not qualify for Medicaid.

    -          Reducing Insurance Barriers to Treatment by ensuring that patients are able to take advantage of cancer drugs that can be taken orally (rather than via an IV) without incurring unfair costs.

    -          Participation in the Washington, D.C. Race for the Cure and raise funds for community programs in the National Capital Region, which has one of the highest incidence and mortality rates for breast cancer in the U.S.

    We encourage each of you join us by becoming an advocate. Our voices combined can save lives and change the future.

  • Choose How to Live Out Your Life

    The following blog appeared in The Huffington Post on April 13, 2015.

    I once asked a simple question to a roomful of young residents I was training: “How many of you have advance medical directives?” Of course, all of them were in their 20s and in good health. No hands were raised and there was a good deal of laughter. I then asked a follow-up question: “How many of you can say with 100 percent certainty that you won’t get hit by a bus today?”

    No one laughed as I went on to tell those young doctors that advance directives allow you to have options. You get to decide what you want in the event of an accident or catastrophic illness–and you spare your family the burden of making wrenching decisions, unaware of your desires.

    Unfortunately, in my time as a practicing physician, I saw the pain and stress families endured when a person had a severe stroke, or was gravely injured in a car accident, and there were no advance directives concerning treatment preferences or who was to make medical decisions.

    That’s why April 16 should be an important date on our calendars. It’s National Healthcare Decisions Day, or NHDD. It’s also the date following the day our taxes are due, for as Benjamin Franklin wrote, “In this world, nothing can be said to be certain except death and taxes.”

    NHDD’s chair Nathan Kottkamp says this 50-state annual initiative aims to demystify health care decision-making and help people understand that it’s not just a matter of creating a living will–it’s a process that should start by having a conversation with family and friends, and choosing a person to carry out your wishes.

    While it is an issue that should be considered by all adults, I think it’s especially important for anyone living with a chronic, potentially life-limiting disease, whether it’s breast cancer, Parkinson’s, renal failure or some other condition. Advance directive planning should really be regarded as part of the continuum of care. It is the only concrete way to make sure your wishes are respected if you are unable to speak for yourself.

    My own family’s experience shows how vital this planning is. After my father’s first stroke, he and my mother put together an advance directive. Years later, my father had a massive stroke and my mother, of course, called 911. In the turmoil, the EMTs didn’t notice the living will on the refrigerator and before my mother could tell them about it, they had intubated my father’s trachea so he could breathe. But because my father had an advance directive and wished to be an organ donor, ultimately we were able to carry out his wishes, keeping him alive long enough to donate his liver, kidneys, and corneas.

    As emotional as the entire experience was for my family, it underscored the importance of making one’s wishes known in advance. That’s why I have a power of attorney for health care, as well as a clear statement of what I want done if, for example, I lose the ability to communicate my wishes. My children know my preferences and now since they are now all young adults, my next job is to get them to think about their own advance directives.

    If you haven’t thought about advance directives yet, I hope April 16 will spur you to do so. Please remember that once you make your decisions, they are not set in stone. Life circumstances change and your preferences can change as well. Indeed, that’s why a key document is called a “living will.”

    So I urge you to set aside April 16 for a visit to the National Healthcare Decisions Day website at www.nhdd.org. There, under the Resources tab, you will find links to a wealth of information from AARP, the American Bar Association, and other respected organizations to help guide you in developing your own advance directives.

  • “Popping Up” around Town to Offer Free Breast Health Services

    By: Komen Northwest Louisiana Mission Coordinator Kelley Matkins

    Every two years, Komen Northwest Louisiana travels across our ten parish (county) service area to conduct our Community Profile – the way that we assess how we can best serve our community. Earlier this year, we saw a tremendous need that was not being met:  lack of both breast health education and awareness of free breast cancer screenings.

    Working with three of our local grantees, the Komen Northwest Louisiana team set out to brainstorm a new way to provide better outreach, visibility and impact of local services throughout 2015. Through the collaboration and creativity of our grantees, the “Pop Up” concept was born, and four priority areas were identified: Ringgold, Mansfield, Springhill and Minden, Louisiana.

    The idea was to “pop up” in a targeted priority community at a high visibility location, such as a grocery store or discount store, and provide a quick and convenient place to share breast cancer education, and offer clinical breast exams and mammograms.

    The idea was simple in nature, but would not have been possible without the support of our grantees, including Partners in Wellness Mobile Mammography Unit (PIW), St. Luke’s Episcopal Mobile Medical Ministry and Martin Luther King Health Center. We also engaged local businesses to get the word out, enlisting the help of business staff to encourage customers, friends and family members who do not have health coverage and those who had questions about breast cancer awareness to stop by the Pop Up and take advantage of the services Komen funds locally.

    Beginning with the first Pop Up in Ringgold, LA, held in the parking lot near a grocery store, we could see the impact of these events firsthand. It was so encouraging to walk into a dry cleaners or café and see faces light up as we spoke to the staff about what Komen Northwest Louisiana does, or how they (or their friends/family members!) can benefit from the services our community grantees provide.

    Komen Northwest Louisiana Executive Director Lindsay Dean was equally excited, sharing, “These Pop Ups are a great way to not only showcase how fundraising directly benefits the local community, but it also helps people in these high priority areas put a face to the Komen Northwest Louisiana name.”

    We knew that we were covering new ground with these Pop Up events, and our first Pop Up wasn’t without a few hiccups. But, we were able to apply what we learned to our second stop, in Mansfield, LA. Thanks to our refreshed approach and a beautiful sunny day, more than 30 women received free breast cancer screenings that day.

    The effects of these events go beyond screening tests, too. In just two short months, our team has noticed a positive change in the public’s perception of breast cancer, with many individuals being more open to discussing their personal experiences with breast cancer.

    Throughout 2015, we plan to schedule one Pop Up a month, rotating our stops in each of the four priority areas identified through our 2015 Community Profile. In doing so, we will visit each area three times throughout the year.

    Our team has been so inspired what collaboration and creativity can do for a community. Thank you to each of the individuals involved in making these Pop Ups possible! We are pleased to have another opportunity to serve our neighbors throughout the year.

    For more information about what’s going on in your area, click here to find your local Komen Affiliate and see how you can get involved!


  • One Tissue Donation, Twenty Samples and Endless Possibilities for Breast Cancer Research

    By Jill Elaine Henry, COO of the Komen Tissue Bank

    In order to recognize something as “abnormal,” you first have to know what is normal. It’s like when you notice that you have a runny nose or a sore throat, and wonder if you’ve caught a cold.

    We know cancer cells are abnormal because they don’t act like normal cells. They are invasive, they evade our immune system, and they spread (or metastasize). So, in order to target and stop breast cancer cells dead in their tracks, researchers first have to understand what exactly makes breast cancer cells different from normal breast cells. And to determine that, they need healthy, disease-free breast tissue.

    The Susan G. Komen Tissue Bank at the IU Simon Cancer Center is the only known repository for healthy breast tissue in the world. We rely on tissue donations from generous women who want to make a very personal contribution to breast cancer research.

    Each time a woman donates tissue, she is making it possible to create 20 or more individual samples (a collection of blood, serum, plasma and breast tissue) that can be used by researchers. This support is so vital because each year we receive requests from researchers around the world in need of these samples.

    The quantity of samples needed can vary from as little as three to as many as 1,000. Additionally, studies often have specific needs, such as only tissue from African-American women or only blood from women who have recently entered menopause. And, just like other resources, it will run out if not replenished. We need help to ensure that these samples are available, and researchers have the tools they need.

    Our neighbors here in Indiana have been nothing short of amazing supporters over the years, but, in order to reach a more diverse population (and get a wider array of samples), sometimes we take the Tissue Bank on the road. Most recently: to Houston, TX.

    Hosting a remote tissue collection event is no easy task, so we were grateful to have the support of Komen Houston, Baylor College of Medicine and lots of local volunteers. We took over the Baylor facility for a day, and worked with community organizations to encourage women of Latina/Hispanic and Asian backgrounds to donate tissue. By the end of the day, samples were collected from more than 160 women.

    I’m excited to share that we’ll be heading to Detroit in 2016 for another tissue collection event. I’m looking forward to meeting the dedicated women in that community as well.

    Wise words tell us, “do something today that your future self will thank you for.” What about something that future generations will thank you for? It may have been just a tissue sample, but these women have made an impact for years to come.

    Any donation – whether it’s money, tissue or time – brings us one step closer to a world without breast cancer. A special thanks to each of you for being a part of this important work.

    If you have questions about the Komen Tissue Bank, the tissue collection process or anything else, check out our website for more information. You can also take a look at all of the studies that have used donated tissue samples to make progress against this disease.